PDA comments: Active pharmaceutical ingredients/guidance

被引：0
|
作者：
Fry, EM
机构：
来源：
PDA JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY | 1997年 / 51卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [1] FDA guidance for industry - Manufacturing, processing, or holding active pharmaceutical ingredients
    Herbst, P
    PHARMAZEUTISCHE INDUSTRIE, 1998, 60 (05): : 435 - 436
  • [2] Polymorphism of active pharmaceutical ingredients
    Karpinski, PH
    CHEMICAL ENGINEERING & TECHNOLOGY, 2006, 29 (02) : 233 - 237
  • [3] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [4] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [5] Active pharmaceutical ingredients/pharmaceutical fine chemicals in Spain
    Beaus, R
    CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (05) : 15 - 16
  • [6] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    ENVIRONMENTAL CHEMISTRY LETTERS, 2025, 23 (01) : 1 - 6
  • [7] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [8] Active pharmaceutical ingredients are big business
    Stoker, A
    TCE, 2002, (732): : 38 - 39
  • [9] Precision active pharmaceutical ingredients are the goal
    Miller, Andrew D.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (11) : 1209 - 1238
  • [10] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    CHEMMEDCHEM, 2011, 6 (06) : 975 - 985
12345